Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 289

Results For "SSI"

5649 News Found

Venus Remedies earns REO Certification from CII for second consecutive year
News | October 26, 2023

Venus Remedies earns REO Certification from CII for second consecutive year

The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)


BASF Pharma Solutions introduces premium services to its VPAs digital services platform
Digitisation | October 25, 2023

BASF Pharma Solutions introduces premium services to its VPAs digital services platform

Additional premium services in RegXcellence will include access to BASF’s Product Carbon Footprint data and direct downloads of audit reports


Innocan Pharma reports discovery regarding its LPD platform and global CBD research
News | October 25, 2023

Innocan Pharma reports discovery regarding its LPD platform and global CBD research

The company expects that this development could improve the strength of its application to the FDA for new drug approval


Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer
News | October 25, 2023

Sumitomo Pharma announces authorization in Canada of Orgovyx for treatment prostate cancer

Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada


Natco Pharma receives 8 observations from USFDA for Pharma Division at Kothur
Drug Approval | October 23, 2023

Natco Pharma receives 8 observations from USFDA for Pharma Division at Kothur

The company is confident of addressing all the observations within the stipulated time


Zhimeng Biopharma CB03 receives Orphan Drug Designation from the USFDA
Drug Approval | October 23, 2023

Zhimeng Biopharma CB03 receives Orphan Drug Designation from the USFDA

CB03 is a candidate drug for the treatment of ALS and other central nerve system (CNS) diseases


ERS Genomics completes licensing agreement with Syngene International
News | October 23, 2023

ERS Genomics completes licensing agreement with Syngene International

Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners


India should take global leadership with Holistic Healthcare Approach: Sonowal
Policy | October 23, 2023

India should take global leadership with Holistic Healthcare Approach: Sonowal

New Molecular biology lab launched, AIIA increased its work scope in form of MoUs


FDA approves only vaccine Penbraya for treatment of meningococcal disease in adolescents
Drug Approval | October 21, 2023

FDA approves only vaccine Penbraya for treatment of meningococcal disease in adolescents

The vaccine further advances Pfizer’s vaccine portfolio and builds on more than 20 years of expertise and knowledge in the prevention of meningococcal disease


Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery
News | October 21, 2023

Evonik strengthens nanoparticle technologies and services portfolio for parenteral drug delivery

Three block copolymers added to RESOMER portfolio of bioabsorbable polymers